BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Credit Suisse maintains outperform on Dr Reddy's
DRL has pipeline visibility until 2020 in the US. Expect 12-15 launches annually. DRL expects to be among the top five in bio-similars. Target at Rs 2850.